Skip to content
OpenCapital
Get started

Chemours CC Deferred and other income taxes

Other financials

Income statement

See full
Revenue$1.4B+1.0%
Gross profit$212.0M-10.2%
Net income-$29.0M-480%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$563.0M+21.3%
Total debt$4.4B0.0%
Total equity$215.0M-62.0%
Total assets$7.3B-1.5%

Cash flow

See full
Operating cash flow-$44.0M+60.7%
CapEx$49.0M-41.7%
Free cash flow-$93.0M+52.6%

Valuation

See full
Market cap$3B+63.6%

Profitability

See full
Gross margin15.1%-3.8pp
Net margin-7%-7.3pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndTaxCredits.

The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Chemours's deferred and other income taxes?
Chemours (CC) reported deferred and other income taxes of -$11M in Q1 2026.
How has Chemours's deferred and other income taxes changed year-over-year?
Chemours's deferred and other income taxes increased by 21.4% year-over-year, from -$14M to -$11M.
What is the long-term trend for Chemours's deferred and other income taxes?
Over 3 years (2021 to 2024), Chemours's deferred and other income taxes has grown at a -24.6% compound annual growth rate (CAGR), from -$77M to -$33M.